IN VITRO DISSOLUTION AND PILOT PHARMACOKINETIC STUDIES OF ACETYLSALICYLIC ACID FROM AN ORALLY DISINTEGRATING TABLET FORMULATION OF LOW-DOSE ASPIRIN

Journal Title: International Journal of Medical and Clinical Research - Year 2011, Vol 2, Issue 2

Abstract

Purpose: Low-dose aspirin (acetylsalicylic acid; ASA) is in routine use today in preventing myocardial infarction and cardiovascular events. Fasprin® (ASA, 81 mg) is a new orally disintegrating tablet formulation of low-dose ASA (ODA) that was designed as a fast-acting, quick-dissolving solid dosage form. The purpose of this work was to (1) evaluate, comparatively, the in vitro dissolution, and (2) evaluate the absorption kinetics of ASA in healthy adults following oral administration of the ODA product. Methods: USP type II dissolution apparatus was implemented in the dissolution studies. For the pharmacokinetic studies, a single ODA dose was administered and blood samples were collected and analyzed for ASA content using a validated HPLC method. Absorption-related pharmacokinetic parameters were estimated using WinNonlin®. Results: Dissolution rate and extent of ASA from the ODA formulation were either higher than or similar to those from leading aspirin-containing products. Noncompartmental pharmacokinetic analysis of ASA plasma profiles from the ODA product revealed a lag-time of at least three minutes. The maximum concentration (Cmax) of ASA was 0.61 µg/mL and the time of Cmax (tmax) ranged from 15 - 75 minutes. The elimination rate constant of ASA was 0.0245 min-1, corresponding to a terminal t½ of 28.3 minutes. Conclusion: The ODA product demonstrated favorable dissolution compared to some leading ASA-containing products. It also provided systemic concentration of ASA at a relatively early time. While the overall absorption kinetics of the ODA product was generally comparable to those from other low-dose ASA-containing products, a direct product comparison is warranted.

Authors and Affiliations

ROJEAB YOUSIF, MARTIN B. SHANE, ROBIN WHITE, SUSAN MONTENERY, MARY MCWILLIAMS, MARJORIE WALKER, DAVID KISOR

Keywords

Related Articles

NOISE-INDUCED HEARING LOSS (NIHL) AND ITS CORRELATION WITH AUDIOMETRIC OBSERVATIONS IN HEAVY VEHICLE OPERATORS SUFFERING WITH METABOLIC DISORDERS

Type II diabetic Mellitus (DM) is a chronic metabolic disease. In 2014, 9% of adults 18 years and older had diabetes. In 2012, diabetes was the direct cause of 1.5 million deaths. More than 80% of diabetes deaths occur i...

QUANTITATIVE D-DIMER LEVELS BY A LATEX ENHANCED IMMUNOTURBIDIMETRIC TEST IN EGYPTIAN PATIENTS WITH BUDD-CHIARI SYNDROME

Backgrounds: Budd-Chiari Syndrome (BCS) is a hepatic venous outflow obstruction at any level between the hepatic veins and the right atrium Objective: to assess quantitative D-dimer levels in BCS cases and using it as a...

NUTRITIONAL ASSESSMENT OF MEDICAL STUDENTS

The objective of this study was to determine nutrient intake and food consumption patterns among medical students at Mahatma Gandhi Mission’s Medical College Aurangabad, Maharashtra state, INDIA. This study was carried...

ESTIMATION OF STATURE FROM FOOT DIMENSIONS OF SCHOOL AGE GROUP CHILDREN IN MAHARASHTRA STATE

The present study is based on measurement of foot length of 200 students of two age groups - 6 to 8 yr & 12 to14 yr. Foot length (heel to tip of each digit), foot width, foot girth at metatarsophalangeal joints & stature...

CO-RELATION OF HEIGHT WITH FOOTLENGTH, FOOTBREADTH AND FOOTHEIGHT OF AN INDIVIDUAL

Footlength has been found to be a simple & effective method in human growth monitoring. Studies have been carried out in estimation of height from footlength as measured from footprints or shoe size & regression equation...

Download PDF file
  • EP ID EP170030
  • DOI 10.9735/0976-5530.2.2.72-77
  • Views 120
  • Downloads 0

How To Cite

ROJEAB YOUSIF, MARTIN B. SHANE, ROBIN WHITE, SUSAN MONTENERY, MARY MCWILLIAMS, MARJORIE WALKER, DAVID KISOR (2011). IN VITRO DISSOLUTION AND PILOT PHARMACOKINETIC STUDIES OF ACETYLSALICYLIC ACID FROM AN ORALLY DISINTEGRATING TABLET FORMULATION OF LOW-DOSE ASPIRIN. International Journal of Medical and Clinical Research, 2(2), 72-77. https://www.europub.co.uk/articles/-A-170030